Intermediate for Venetoclax. Venetoclax (trade name Venclexta) is a small molecule oral drug that treats chronic lymphocytic leukemia (CLL) in those with a specific chromosomal abnormality. Venetoclax is a BH3-mimetic and acts as a Bcl-2 inhibitor. Venetoclax has been approved by US FDA om April 11, 2016.


Product Name:                  3-Nitro-4-(((tetrahydro-2H-pyran-4-yl)methyl)amino)benzenesulfonamide

Synonyms:                         N/A

CAS Number:                     1228779-96-1

Molecular Weight:            315.3434

Molecular Formula:          C12H17N3O5S

Purity (HPLC):                     ≥95%

Shipping Conditions:         Room temperature.

Storage Conditions:           Refrigerated.

Regulatory Statement:      For Research Use Only.

SMILES:                               [O-][N+](=O)c1cc(ccc1NCC1CCOCC1)S(=O)(=O)N


  • $138.00
  • Ex Tax: $138.00

Available Options